Effect of EPA for Diabetes mellitus

Effect of EPA for Diabetes mellitus - Effect of EPA for Diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017071

Enrollment

Registered

2015-04-08

Start date

2015-04-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

oral drug continuous glucose monitoring

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Physician-diagnosed diabetes mellitus concomitant with dyslipidemia

Exclusion criteria

Exclusion criteria: There is medical past history of allergic to the eicosapentaenoic acid (EPA) impossible to perform the continuous glucose monitoring due to patient situations

Design outcomes

Primary

Measure	Time frame
Significant improvement of glucose fluctuation with continuous glucose monitoring	—

Countries

Japan

Contacts

Public ContactKoichiro Matsumura

Kansai Medical University Takii Hospital Department of medicine II

kmatsumura1980@yahoo.co.jp06-6992-1001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026